Dear MRI Insider,
Strong evidence of 7-tesla MRI's clinical usefulness remains in relatively short supply, so a new musculoskeletal study from Pisa, Italy, seems certain to generate considerable interest.
The researchers were keen to optimize sequences for in vivo articular cartilage imaging at 7-tesla MRI and to investigate the diagnostic potential of ultrahigh-field MRI in detecting early changes of the articular cartilage related to physiological aging. They even developed their own volume coil, and it proved a success. To read more, click here.
Debate continues over the safety of MRI contrast agents, so it came as no surprise that this topic featured prominently at the recent 98th German Radiology Congress in Leipzig. A group from Düsseldorf presented new information at the meeting, and you can get it here. Also, the U.S. Food and Drug Administration issued its long-awaited review on 22 May, and you can click here to learn more.
The emergence of online MR-guided radiotherapy promises unparalleled soft-tissue image contrast and the ability to "see what you treat," according to Bas Raaymakers, PhD, from University Medical Center Utrecht in the Netherlands. He's convinced the technique offers major benefits compared with image guidance by cone-beam CT. Click here for the details.
A fast cardiovascular MR scan is a cost-effective way to examine large volumes of patients with a wide range of suspected heart conditions, said researchers from Peru in a presentation on 26 May at the EuroCMR 2017 meeting in Prague. Get the full story here.
This letter features only a small selection of the numerous articles posted over the past few weeks in the MRI Community. Please scroll through the full list of our coverage below.
